SEC Form 4 · accession 0001645627-17-000128
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 13, 2017
Accepted (ET)
Oct 17, 2017 · 11:28 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 13, 2017 | P | 3,000 | $0.0988 | A | 23,778,189 | D | |
| Common Stock | Oct 13, 2017 | P | 3,000 | $0.0945 | A | 23,781,189 | D | |
| Common Stock | Oct 13, 2017 | P | 3,000 | $0.0845 | A | 23,784,189 | D | |
| Common Stock | Oct 13, 2017 | P | 3,000 | $0.081 | A | 23,787,189 | D | |
| Common Stock | Oct 13, 2017 | P | 3,000 | $0.09 | A | 23,790,189 | D | |
| Common Stock | Oct 13, 2017 | P | 3,000 | $0.0869 | A | 23,793,189 | D | |
| Common Stock | Oct 13, 2017 | P | 3,000 | $0.0845 | A | 23,796,189 | D | |
| Common Stock | Oct 13, 2017 | P | 3,000 | $0.0845 | A | 23,799,189 | D | |
| Common Stock | Oct 16, 2017 | P | 2,000 | $0.0695 | A | 23,801,189 | D | |
| Common Stock | Oct 16, 2017 | P | 2,000 | $0.068 | A | 23,803,189 | D | |
| Common Stock | Oct 16, 2017 | P | 2,000 | $0.0669 | A | 23,805,189 | D | |
| Common Stock | Oct 16, 2017 | P | 2,000 | $0.0664 | A | 23,807,189 | D | |
| Common Stock | Oct 16, 2017 | P | 5,000 | $0.06 | A | 23,812,189 | D | |
| Common Stock | Oct 16, 2017 | P | 5,000 | $0.0679 | A | 23,817,189 | D | |
| Common Stock | Oct 16, 2017 | P | 2,000 | $0.069 | A | 23,819,189 | D | |
| Common Stock | Oct 16, 2017 | P | 3,000 | $0.069 | A | 23,822,189 | D | |
| Common Stock | Oct 16, 2017 | P | 2,000 | $0.0689 | A | 23,824,189 | D | |
| Common Stock | Oct 16, 2017 | P | 2,000 | $0.0685 | A | 23,826,189 | D |
Table II — derivative securities
No Table II lines on this filing.